Will There be More Clarity About the CGM Landscape at ATTD?
There could be an opportunity to gain more insight into how the continuous glucose monitoring (CGM) market will pan out this year at the 2020 International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). The leading companies in the space are slated to release data and give investors more clarity about CGM offerings, according to a report from Canaccord and Genuity analyst Kyle Rose. Abbott Laboratories’ upcoming Freestyle Libre 2 will be a major topic in the CGM conversation during ATTD because it will reshape the market’s landscape. Already patients and invest...
Source: MDDI - February 15, 2020 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news

2020 Prescription Drug Survey: West Virginia Registered Voters 18+
Enter a keyword below to find answers to your AARP Research questions. ... Three quarters (75%) of adults incorrectly believe that memory loss is a normal and natural part of aging. ... You are lea... (Source: AARP.org Policy and Research)
Source: AARP.org Policy and Research - February 14, 2020 Category: American Health Source Type: news

Prescription Costs Burden Washington Residents Ages 45 and Older
Enter a keyword below to find answers to your AARP Research questions. ... Three quarters (75%) of adults incorrectly believe that memory loss is a normal and natural part of aging. ... You are lea... (Source: AARP.org Policy and Research)
Source: AARP.org Policy and Research - February 9, 2020 Category: American Health Source Type: news

Janssen to Highlight Depth of Solid Tumor Portfolio at ASCO GU
RARITAN, N.J., February 3, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple data presentations from a robust solid tumor portfolio that will be featured at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15 in San Francisco. Company-sponsored data presentations will include clinical results for ERLEADA® (apalutamide) and niraparib in prostate cancer; and BALVERSA™ (erdafitinib) in bladder cancer. “We are committed to improving outcomes in patients with prostate and bladder cancer where high unmet...
Source: Johnson and Johnson - February 3, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

2019 Prescription Drug Survey: New York Registered Voters 50+
Enter a keyword below to find answers to your AARP Research questions. ... Three quarters (75%) of adults incorrectly believe that memory loss is a normal and natural part of aging. ... You are lea... (Source: AARP.org Policy and Research)
Source: AARP.org Policy and Research - January 31, 2020 Category: American Health Source Type: news

Biogen's multiple sclerosis drug powers quarterly profit beat
Biogen Inc's top-selling multiple sclerosis drug helped the company's quarterly profit beat market expectations on Thursday, sending its shares up about 2% before the bell. (Source: Reuters: Health)
Source: Reuters: Health - January 30, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Eli Lilly profit tops estimates on diabetes drug strength
Eli Lilly and Co reported a higher-than-expected quarterly profit on Thursday, helped by strong demand for its diabetes drug, Trulicity, and psoriasis treatment, Taltz. (Source: Reuters: Health)
Source: Reuters: Health - January 30, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Factbox: Tesla, Apple, Starbucks warn of virus hit; firms restrict travel, flights cancelled
Tesla warned a delay in the output of Shanghai-built Model 3 cars would hurt first-quarter profit after China ordered a shutdown of the factory following a virus outbreak that has killed 170 people and infected thousands. (Source: Reuters: Health)
Source: Reuters: Health - January 30, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

GE Healthcare generating 'profitable growth,' says parent company
GE Healthcare, which has about 6,000 employees in metro Milwaukee, continues to be a bright spot for General Electric Co. with GE CEO Larry Culp saying the unit has opportunities to grow. GE Healthcare recorded flat revenue and a 1% increase in profits during the fourth quarter of 2019, Boston-based General Electric (NYSE: GE) said Wednesday. Corporatewide, total fourth-quarter revenue for GE was down by 1% but the profit margin in the company’s industrial operations, including health care,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 29, 2020 Category: Pharmaceuticals Authors: Rich Kirchen Source Type: news

GE Healthcare generating 'profitable growth,' says parent company
GE Healthcare, which has about 6,000 employees in metro Milwaukee, continues to be a bright spot for General Electric Co. with GE CEO Larry Culp saying the unit has opportunities to grow. GE Healthcare recorded flat revenue and a 1% increase in profits during the fourth quarter of 2019, Boston-based General Electric (NYSE: GE) said Wednesday. Corporatewide, total fourth-quarter revenue for GE was down by 1% but the profit margin in the company’s industrial operations, including health care,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 29, 2020 Category: Biotechnology Authors: Rich Kirchen Source Type: news

Abbott Patients Grow Impatient for Libre 2 Approval
Abbott Laboratories has been wildly successful with its FreeStyle Libre continuous glucose monitor (CGM) since winning FDA approval in 2017, but it seems some investors and patients may be getting restless as the U.S. market waits for the second-generation of the blockbuster technology. We first noted some signs of impatience for Libre 2 in our coverage of Abbott's third-quarter earnings call in October. One reader commented on that article that "I don’t particularly care about investors becoming impatient, as a Freestyle Libre user I am growing impatie...
Source: MDDI - January 23, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Coronavirus set to impact Chinese airlines' first quarter profit: Aercap CEO
The chief executive of one of the world's largest aircraft lessors, Aercap , expects the new coronavirus that has emerged from Wuhan, China to impact Chinese airlines' profitability in the first quarter. (Source: Reuters: Health)
Source: Reuters: Health - January 22, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Women Activists Escalate Demand for “Bodily Autonomy” as 19 Nations Dissent
Credit: UN WomenBy Thalif DeenUNITED NATIONS, Jan 17 2020 (IPS) The United States and 18 other UN member states have come under fire for denying a woman’s legitimate right to “bodily autonomy”—the right to self-governance over one’s own body without coercion or external pressure. The Executive Director of Women’s March Global, Uma Mishra-Newbery, told IPS the United Nations has worked towards progress in fighting for women’s rights. But many countries on the Human Rights Council continue to negotiate women’s human rights off the table, she pointed out. In Sept 2019, she sa...
Source: IPS Inter Press Service - Health - January 17, 2020 Category: International Medicine & Public Health Authors: Thalif Deen Tags: Featured Gender Global Headlines Health Human Rights IPS UN: Inside the Glasshouse TerraViva United Nations Women's Health Source Type: news

UnitedHealth bets on government health plan growth in 2020
UnitedHealth Group Inc, the largest U.S. health insurer, reported a better-than-expected fourth-quarter profit on Wednesday, and said it expects strong sales of its government health plans this year. (Source: Reuters: Health)
Source: Reuters: Health - January 16, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Pharmacy unit boosts UnitedHealth as costs rise
UnitedHealth Group Inc reported a better-than-expected quarterly profit on Wednesday, as the largest U.S. health insurer managed to control medical costs and made gains with the unit that houses its pharmacy benefits management business. (Source: Reuters: Health)
Source: Reuters: Health - January 15, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

1 in 6 women suffer PTS after a miscarriage, study shows
Better care needed for early-stage pregnancy loss Related items fromOnMedica Antenatal depression rife, but hidden from doctors Quarter of pregnant women have mental health problems All women must have access to perinatal mental health service Assess pregnant and new mums ’ mental health Significant rise in access to perinatal mental health care (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 15, 2020 Category: UK Health Source Type: news

AstraZeneca to discontinue Epanova trial, expects $100 million writedown
AstraZeneca said on Monday it will discontinue a late-stage trial for heart disease drug Epanova to treat patients with mixed dyslipidaemia and expects a $100 million writedown to hit its core profit in the fourth quarter. (Source: Reuters: Health)
Source: Reuters: Health - January 13, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Menopausal Symptoms: There's a Place for Tech-Related Solutions
Enter a keyword below to find answers to your AARP Research questions. ... Three quarters (75%) of adults incorrectly believe that memory loss is a normal and natural part of aging. ... You are lea... (Source: AARP.org News)
Source: AARP.org News - January 9, 2020 Category: American Health Source Type: news

Walgreens Mum On Buyout As Profits Fall 25%
Walgreens Boots Alliance profits dipped in the company ’s fiscal first quarter as the company works to reinvent its U. S. drugstores amid rumors the the global chain may be taken private in a massive leveraged buyout. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 8, 2020 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Walgreens first-quarter profit falls nearly 25% on higher costs
Drugstore chain Walgreens Boots Alliance Inc posted a 24.8% drop in quarterly profit on Wednesday, hurt by higher costs related to its acquisition of stores from rival Rite Aid Corp (Source: Reuters: Health)
Source: Reuters: Health - January 8, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Reflections for a New Year
By Roberto SavioROME, Jan 3 2020 (IPS) In a world shaken by so many problems, it is difficult to look at 2020 and not make some kind of holistic analysis. While enormous progress has been made on many fronts, it is clear that the tide has turned, and we are now entering – or have already entered – a new low point in the history of humankind.. Roberto SavioToday, we face an unprecedented existential threat brought about by the climate crisis. According to scientists, we have until 2030 to stop climate change, after which human conditions will be under several threats. Yet, we have just had a world conference in...
Source: IPS Inter Press Service - Health - January 3, 2020 Category: International Medicine & Public Health Authors: Roberto Savio Tags: Climate Change Democracy Economy & Trade Education Environment Featured Financial Crisis Gender Global Headlines Health Human Rights LGBTQ Migration & Refugees Poverty & SDGs Religion TerraViva United Nations Source Type: news

Antitrust settlement pushes Sutter Health to quarterly loss
Sutter Health's $575 million antitrust settlement pushed the Sacramento-based health care system to a $651 million loss in the third quarter. The nonprofit hospital system had $49 million in income in the third quarter of last year. In its third-quarter financial statement filed with municipal bond market regulators, Sutter said it agreed to settle the case “to avoid the cost of a protracted trial combined with years of appeals.” The lawsuit by California Attorney General Xavier Becerra and… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 25, 2019 Category: Biotechnology Authors: Mark Anderson Source Type: news

Antitrust settlement pushes Sutter Health to quarterly loss
Sutter Health's $575 million antitrust settlement pushed the Sacramento-based health care system to a $651 million loss in the third quarter. The nonprofit hospital system had $49 million in income in the third quarter of last year. In its third-quarter financial statement filed with municipal bond market regulators, Sutter said it agreed to settle the case “to avoid the cost of a protracted trial combined with years of appeals.” The lawsuit by California Attorney General Xavier Becerra and… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 25, 2019 Category: Pharmaceuticals Authors: Mark Anderson Source Type: news

Roche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophy
Basel, 23 December 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Sarepta Therapeutics, Inc. (NASDAQ:SRPT), today announced the signing of a licensing agreement providing Roche exclusive commercial rights to SRP-9001 (AAVrh74.MHCK7.micro-dystrophin),   Sarepta’s investigational gene therapy for Duchenne muscular dystrophy (DMD), outside the United States. Under the terms of the agreement, Sarepta will receive an upfront payment of $750million in cash and $400million in equity. In addition, Sarepta is eligible to receive regulatory and sales m ilestones, and royalties on net sales. Roche and Sarepta will equally s...
Source: Roche Media News - December 23, 2019 Category: Pharmaceuticals Source Type: news

Roche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophy
Basel, 23 December 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Sarepta Therapeutics, Inc. (NASDAQ:SRPT), today announced the signing of a licensing agreement providing Roche exclusive commercial rights to SRP-9001 (AAVrh74.MHCK7.micro-dystrophin),   Sarepta’s investigational gene therapy for Duchenne muscular dystrophy (DMD), outside the United States. Under the terms of the agreement, Sarepta will receive an upfront payment of $750million in cash and $400million in equity. In addition, Sarepta is eligible to receive regulatory and sales m ilestones, and royalties on net sales. Roche and Sarepta will equally s...
Source: Roche Investor Update - December 23, 2019 Category: Pharmaceuticals Source Type: news

Dealing With Stress
Enter a keyword below to find answers to your AARP Research questions. ... Three quarters (75%) of adults incorrectly believe that memory loss is a normal and natural part of aging. ... You are lea... (Source: AARP.org Policy and Research)
Source: AARP.org Policy and Research - December 19, 2019 Category: American Health Source Type: news

eyeforpharma Awards: Recognizing and celebrating innovation
At the eyeforpharma Awards we strive to reward, support and incentivise innovation, especially when it comes to the value pharma offers patients and customers. We only recognize meaningful innovation which takes our industry, our reputation and our impact forward and the entries are measured objectively by external judges.  I was amazed by the quality of entries this year. With 500 nominations, our judges – a mixture of patients and health professionals – deliberated hard for many hours, finally settling on just 16 winners, each exemplifying the very best work in pharma.   By ‘best’...
Source: EyeForPharma - December 19, 2019 Category: Pharmaceuticals Authors: Paul Simms Source Type: news

' Never Too Late' to Lower Breast Cancer Risk via Weight Loss'Never Too Late' to Lower Breast Cancer Risk via Weight Loss
Women in their 50s who lose 20 pounds or more in weight could cut their risk for breast cancer by more than a quarter, say US researchers reporting a large study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cuts … not just Brexit
Just weeks ago, as the general election campaign started to pick up speed, NHS England released some interesting data: accident and emergency waiting times were the worst on record. It didn’t get that much traction in a media concentrating on the run-up to the political theatre of the first party leaders’ debate. But as fullfact.org spelled out: “In October 2019, 83.6% of patients attending all types of A&E departments (including things like dental A&E and urgent care centres) in England were admitted, transferred or discharged within four hours.” A year ago, 89.1% were seen within the four-...
Source: UNISON meat hygiene - December 6, 2019 Category: Food Science Authors: Tony Braisby Tags: P.S data activists ge19 general election 2019 Source Type: news

School technician cuts put safety at risk
Almost a third of secondary school technicians (32%) think staff cuts are putting pupil safety at risk, according to a UNISON study published today (Friday). The findings are from a survey of 500 technicians – who support science, IT, design and technology teachers – and highlight the importance of these specialist roles, says UNISON. Their work involves preparing equipment and materials, as well as assisting in practical lessons. The figures are published to coincide with UNISON’s annual Stars in our Schools celebration, which highlights the contribution school support staff...
Source: UNISON Health care news - November 29, 2019 Category: UK Health Authors: Charlotte Jeffs Tags: News Press release education school cuts schools Source Type: news

Why You Should Add Rest to Your Workout Routine
Most fitness advice urges people to squeeze in more workouts. That’s reasonable, considering government data show that only about a quarter of American adults meet the current guidelines for adequate physical activity: 150 minutes of moderate or 75 minutes of vigorous aerobic activity per week, plus two bouts of muscle-strengthening exercise. Meeting these guidelines is important, since getting enough exercise can improve an individual’s physical and mental health. But when it comes to exercise, it is possible to have too much of a good thing. In fact, research suggests taking strategic time off from your worko...
Source: TIME: Health - November 27, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Exercise/Fitness Source Type: news

A Tiny Bug Ended My NFL Career —and Almost My Life
During my nine years in the NFL, I ruptured tendons in my fingers, suffered multiple concussions, and broke several bones. I tore my ACL, MCL, and PCL, and completely blew out my left knee. That last injury should have ended my career. But it didn’t. I put myself back together and played through the pain. What finally took me down? A tiny bug I had never heard of and couldn’t see. A drug-resistant staph infection called methicillin-resistant Staphylococcus aureus cost me my NFL career—and almost my life. MRSA is one of many deadly, antibiotic-resistant infections. Together, these “superbugs” k...
Source: TIME: Health - November 19, 2019 Category: Consumer Health News Authors: Brandon Noble Tags: Uncategorized health Source Type: news

Norton Healthcare's profit is up 48% for the year so far
Norton Healthcare Inc. continues its upward financial trajectory by finishing the third quarter significantly ahead of where it was a year ago. The Louisville-based nonprofit hospital and health care provider saw its operating income jump by 48.4% to $106.2 million for the nine months ended September 30, 2019, according to financial disclosure documents for municipal bonds issued on behalf of Norton Healthcare. "While the health care in dustry continues to be faced with challenges, including increased… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 18, 2019 Category: Biotechnology Authors: Chris Larson Source Type: news

Public service workers ready to learn to ease redundancy fears
A third of public service workers are worried they’ll lose their jobs due to technological innovation or government cuts, according to a UNISON survey published today (Thursday). But one in ten feel additional training has protected them from the threat of redundancy, with staff feeling more secure in their jobs because of the new skills they’ve acquired. The findings, from a skills survey of more than 38,000 public sector workers, reveal that a third (34%) believe it ‘likely’ their jobs might go in the next 36 months. But the workforce is overwhelmingly keen to learn, with more than four fifths (81...
Source: UNISON Health care news - November 14, 2019 Category: UK Health Authors: Charlotte Jeffs Tags: News Press release cuts labour learning public services survey Source Type: news

Patients with chronic conditions still neglected on mental health
Quarter of areas do not have integrated mental and physical services Related items fromOnMedica Experts urge radical action on mental health crises Higher cancer risk from chronic diseases Regular not excessive exercise link to better mental health Wearable tech approach to diabetes prevention to expand Weight loss targets exceeded on NHS type 2 diabetes prevention programme (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 11, 2019 Category: UK Health Source Type: news

DexCom Wins Big with 3Q19 Earnings
DexCom is continuing its upward trajectory in sales by bringing in solid 3Q19 earnings. The San Diego-based company toppled consensus estimates and updated sales guidance for the year to $1.43 billion to $1.45 billion compared to previous guidance of $1.33 billion to $1.38 billion. As a result of the earnings, the company’s shares increased by 15% after hours on Wednesday. Kevin Sayer, chairman, president, and CEO of DexCom spoke on the significance of the earnings. “The third quarter represents our highest U.S. growth rate since the first quarter of 2016 when the business was much small...
Source: MDDI - November 7, 2019 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Source Type: news

Teva puts further $468m aside for opioid settlements
Israeli drugmaker reports widening quarterly loss but lifts outlook (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - November 7, 2019 Category: Pharmaceuticals Source Type: news

Medtronic Sues Axonics for Patent Infringement
The medical device industry has seen its share of David vs. Goliath stories over the years, but few have been as intense as the battle between Medtronic and Axonics over the sacral neuromodulation (SNM) market. The story took an unexpected turn this week as Medtronic slapped Axonics with a patent infringement lawsuit that is likely to take years to play out. Medtronic (the Goliath of this story), filed a lawsuit against Axonics Modulation Technologies (the David of the story), alleging infringement of four patents related to Medtronic's SNM lead placement procedure and implant recharging technologie...
Source: MDDI - November 5, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Implants Source Type: news

China Is Bankrolling Green Energy Projects Around the World
Perched on the ochre scrub of Argentina’s sunbaked Puna Jujeña plateau, the $400 million Cauchari power station is the world’s highest-altitude solar farm at 13,000 ft (about 4,000 meters) above sea level. In Kenya’s volcano-strewn Rift Valley, a newly green-lit, super-efficient electrical substation will soon funnel clean power from the nearby Olkaria Geothermal Plant about 50 miles (80 km) to downtown Nairobi. Some 14 miles off blustery northeastern Scotland, Moray East is set to become the world’s largest offshore wind farm, helping to heat and light up to a million homes. Three distinct r...
Source: TIME: Science - November 1, 2019 Category: Science Authors: Charlie Campbell / Shanghai Tags: Uncategorized China onetime overnight Source Type: news

McKesson Reports Fiscal 2020 Second-Quarter Results
Total revenues of $57.6 billion, reflecting 9% growth.Loss per diluted share of $(3.99) and Adjusted Earnings per diluted share of $3.60.Reaffirmed fiscal 2020 Adjusted EPS guidance range of $14.00 to $14.60. (Source: McKesson News)
Source: McKesson News - October 30, 2019 Category: Information Technology Source Type: news

Exact Sciences beats Wall Street expectations with $218M in sales for 3Q
Exact Sciences Corp., the Madison-based technology company that makes cancer diagnostic and detection devices, reported revenue of $218.8 million for its third quarter, beating Wall Street analysts' expectations by just over $2 million. The maker of the Cologuard take-home colon cancer test (Nasdaq: EXAS) reported a net loss of $40.5 million, or 31 cents per share, in the quarter. Analysts had predicted net losses of 41 cents per share. Revenue for the third quarter is up 85% relative to the year-ago… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 29, 2019 Category: Pharmaceuticals Authors: Nick Williams Source Type: news

Exact Sciences beats Wall Street expectations with $218M in sales for 3Q
Exact Sciences Corp., the Madison-based technology company that makes cancer diagnostic and detection devices, reported revenue of $218.8 million for its third quarter, beating Wall Street analysts' expectations by just over $2 million. The maker of the Cologuard take-home colon cancer test (Nasdaq: EXAS) reported a net loss of $40.5 million, or 31 cents per share, in the quarter. Analysts had predicted net losses of 41 cents per share. Revenue for the third quarter is up 85% relative to the year-ago… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 29, 2019 Category: Biotechnology Authors: Nick Williams Source Type: news

Obalon ’s New Sales Model is Coming Together
Obalon Therapeutics said it has treated the first patients at its company-owned weight loss treatment center. The Obalon Center for Weight Loss is a medical facility staffed with physicians specializing in weight loss, nutritional counselors to help patients change their eating habits for sustainable weight loss, and other staff to help provide safe and effective treatment with the Obalon Balloon System. “We opened this direct channel to treat patients in order to improve outcomes and the access and affordability for patients with obesity seeking to lose weight with the Obalon Balloon System, William Plov...
Source: MDDI - October 29, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

J & J slashes third-quarter profit by $3 billion over proposed opioid deal
Johnson& Johnson on Wednesday lowered its previously reported third-quarter profit by $3 billion to account for a proposed opioid settlement payment. (Source: Reuters: Health)
Source: Reuters: Health - October 24, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Surgical Robotics Pioneer Braces for Prolonged Negotiations Due to Incoming Competition
As hot as surgical robotics has been the last two years, the market hasn't seen anything compared to what 2020 is likely to bring. So how is the pioneer in robotically-assisted surgery preparing for its incoming competition? "It is also likely we will see increased price negotiations and elongated negotiation timelines as competition get closer to launching new products," Marshall Mohr, executive vice president and CFO at Intuitive Surgical, said during the company's third-quarter earnings call. "These dynamics could result in profit fluctuations. However, we will continue to manage the business for the long...
Source: MDDI - October 18, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Tuberculosis Infections Declining, But Not Fast Enough Among Poor, Marginalised: UN Health Agency
A 25 year-old tuberculosis patient is treated at her home in Funafuti, the main island of Tuvalu in the South Pacific. Credit: UNDP Tuvalu/Aurélia Rusek.By External SourceUNITED NATIONS, Oct 17 2019 (IPS) A staggering 1.5 million people died from tuberculosis (TB) last year, the UN health agency said on Thursday, in an appeal for far greater funding and political support to eradicate the curable and preventable disease. Caused by the bacteria Mycobacterium tuberculosis, TB commonly causes persistent coughing, fatigue and weight loss. According to the World Health Organization (WHO) and its latest Global TB Report, a...
Source: IPS Inter Press Service - Health - October 17, 2019 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Poverty & SDGs Source Type: news

Are Investors Growing Impatient for FDA Approval of Abbott & #039;s Libre 2 iCGM?
Abbott Laboratories has been wildly successful with its FreeStyle Libre continuous glucose monitor (CGM) since winning FDA approval two years ago, but some investors may be getting restless as the U.S. market waits for the second-generation of the blockbuster technology. Abbott won CE mark approval to launch the Libre 2 system in Europe in October 2018. The second-generation system offers optional customizable glucose alarms for patients who need them, using Bluetooth technology. The system can be set up to alert the user if their glucose is low or high, for example, or if there is a signal loss between the sen...
Source: MDDI - October 17, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

How the Ban on Medical Advertising Hurt Women Doctors
This article was published on JSTOR Daily, read the original article here. (Source: TIME: Health)
Source: TIME: Health - October 16, 2019 Category: Consumer Health News Authors: Olivia Campbell / JSTOR Daily Tags: Uncategorized health medicine onetime syndication Source Type: news

3 Ways Invacare Is Turning Its Business Around
Homecare and long-term care equipment maker Invacare has had a rough go of it in recent years, and tariffs and reimbursement changes in the United States last year didn't make things any easier for the Elyria, Ohio-based company. There does appear to be a light at the end of the tunnel though, and one industry analyst reported positive takeaways from his firm's recent meeting with Invacare management. "We came away feeling positive about [Invacare's] progress on its turnaround after learning more details about the steps it is taking to deliver upon its 2020 and 4Q20 EBITDA targets,&...
Source: MDDI - October 14, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Philips says tariffs will take bite out of Q3 numbers
Profit margins are expected to be lower for the third quarter of 2019 due to...Read more on AuntMinnie.comRelated Reading: Philips, PURE partner on Rwandan teleultrasound Philips asserts it has no intention of buying Corindus Philips, Carestream healthcare IT deal nears completion Philips reports continued sales growth in Q2 Philips integrates AI into latest Epiq CVx upgrade (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 10, 2019 Category: Radiology Source Type: news